Genetic evidence of aberrant striatal synaptic maturation and secretory pathway alteration in a dystonia mouse model
Dystonia · 2022
DOI: 10.3389/dyst.2022.10892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dystonia, 2022. Verfasst von Dhananjay Yellajoshyula und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Case Western Reserve University, Cleveland, OH, United States. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Dystonia Medical Research Foundation, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Animal models of DYT-TOR1A dystonia consistently demonstrate abnormalities of striatal cholinergic function, but the molecular pathways underlying this pathophysiology are unclear. To probe these molecular pathways in a genetic model of DYT-TOR1A, we performed laser microdissection in juvenile mice to isolate striatal cholinergic interneurons and non-cholinergic striatal tissue largely comprising spiny projection neurons during maturation. Both cholinergic and GABAergic enriched samples demonstrated a defined set of gene expression changes consistent with a role of torsinA in the secretory pathway. GABAergic enriched striatum samples also showed alteration to genes regulating synaptic transmission and an upregulation of activity dependent immediate early genes. Reconstruction of Golgi-Cox stained striatal spiny projection neurons from adult mice demonstrated significantly increased spiny density, suggesting that torsinA null striatal neurons have increased excitability during striatal maturation and long lasting increases in afferent input. These findings are consistent with a developmental role for torsinA in the secretory pathway and link torsinA loss of function with functional and structural changes of striatal cholinergic and GABAergic neurons. These transcriptomic datasets are freely available as a resource for future studies of torsinA loss of function-mediated striatal dysfunction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosciences, Case Western Reserve University, Cleveland, OH, United States.
- Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Förderung
- NINDS NIH HHS
- Dystonia Medical Research Foundation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Yellajoshyula, D., Opeyemi, S., Dauer, W. T., & Pappas, S. S. (2022). Genetic evidence of aberrant striatal synaptic maturation and secretory pathway alteration in a dystonia mouse model. Dystonia. https://doi.org/10.3389/dyst.2022.10892
Vancouver
Yellajoshyula D, Opeyemi S, Dauer WT, Pappas SS. Genetic evidence of aberrant striatal synaptic maturation and secretory pathway alteration in a dystonia mouse model. Dystonia. 2022. doi:10.3389/dyst.2022.10892
BibTeX
@article{Yellajoshyula2022,
author = {Yellajoshyula, Dhananjay and Opeyemi, Sunday and Dauer, William T and Pappas, Samuel S},
title = {Genetic evidence of aberrant striatal synaptic maturation and secretory pathway alteration in a dystonia mouse model},
journal = {Dystonia},
year = {2022},
doi = {10.3389/dyst.2022.10892}
}
EUVIMED